...
首页> 外文期刊>Journal of Pathology: Journal of the Pathological Society of Great Britain and Ireland >Overexpression of the 67-kD laminin receptor correlates with tumour progression in human colorectal carcinoma.
【24h】

Overexpression of the 67-kD laminin receptor correlates with tumour progression in human colorectal carcinoma.

机译:67 kD层粘连蛋白受体的过表达与人类大肠癌的肿瘤进展相关。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The high affinity 67-kD laminin receptor (67LR) is a cell surface protein whose expression is increased in a number of human carcinoma models. To date, 67LR expression in colorectal carcinomas has been examined in a small number of cases. 67LR expression has been immunohistochemically analysed in a large series of human colorectal neoplasms, using the MLuC5 monoclonal antibody. The study included 59 samples of non-neoplastic mucosa, 45 polyps (11 hyperplastic, 34 adenomas), 196 carcinomas, and lymph node metastases of 87 carcinomas. Epithelial cells of normal mucosa and hyperplastic polyps were negative or showed weak positivity in the paranuclear and apical areas of the cytoplasm. In adenomas and carcinomas, the staining was stronger, with a membranous or cytoplasmic pattern. The expression of 67LR correlated significantly with the progression from normal mucosa (22 per cent) to adenoma (44 per cent), carcinoma (61 per cent), and lymph node metastasis (75 per cent) (P < 0.0001). Expression of the laminin receptor showed a tendency to be more frequently positive in advanced stage (III+IV; 67 (III+IV; 67 per cent) when compared with early stage (I+II) carcinomas (54 per cent). The difference, however, was not statistically significant (P = 0.058). In addition, 14 out of 28 (50 per cent) primary carcinomas without 67LR expression became positive in lymph node metastases, while most (86 per cent) of the MLuC5-positive primary carcinomas were also immunoreactive in metastases. In conclusion, these results indicate that 67LR is up-regulated in the progression of human colorectal carcinomas and may play a role in the local and metastatic progression of these tumours.
机译:高亲和力67-kD层粘连蛋白受体(67LR)是一种细胞表面蛋白,在许多人类癌症模型中其表达均增加。迄今为止,已经在少数病例中检查了67LR在大肠癌中的表达。已使用MLuC5单克隆抗体在大范围的人类结肠直肠肿瘤中免疫组化分析了67LR表达。该研究包括59份非肿瘤性粘膜样本,45例息肉(11例增生,34例腺瘤),196例癌和87例癌的淋巴结转移。正常粘膜和增生性息肉的上皮细胞在细胞质的核旁和顶端区域呈阴性或呈弱阳性。在腺瘤和癌中,染色更强,具有膜状或细胞质模式。 67LR的表达与从正常粘膜(22%)到腺瘤(44%),癌(61%)和淋巴结转移(75%)的进展密切相关(P <0.0001)。与早期(I + II)癌(54%)相比,层粘连蛋白受体的表达在晚期(III + IV; 67(III + IV; 67%))更倾向于阳性。然而,在统计学上无统计学意义(P = 0.058);此外,在28个不带67LR表达的原发癌中,有14个(50%)在淋巴结转移中呈阳性,而大多数MLuC5阳性的原发癌(86%)总的来说,这些结果表明67LR在人类结直肠癌的进展中被上调,并且可能在这些肿瘤的局部和转移进展中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号